• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Noble launches AdhereIT platform for self-injection training

June 13, 2018 By Sarah Faulkner

NobleNoble this week launched its connected device platform, AdhereIT, to provide people that use auto-injectors with real-time feedback regarding their injection.

Users can attach the AdhereIT system to an auto-injector training device or a commercial product, Noble reported. The platform can detect when the auto-injector makes contact with a user’s skin and the time when an injection starts and ends.

AdhereIT also sends notifications via an app to remind users to practice their injections or when it’s time for them to use their prescribed devices. The system wirelessly transmits real-time feedback to the user, helping them to identify potential administration errors.

AdhereIT can be adapted to an array of commercial auto-injectors, according to Noble.

“There has been a rapid growth of innovative treatments delivered through autoinjectors, which allow patients the convenience of self-administering the drug. Our priority is to help ensure that patients who self-inject feel confident they are using their devices correctly, since studies suggest device familiarity and patient confidence may help improve adherence,” Noble CEO Jeff Baker said in prepared remarks. “We believe our new connected error correcting device platform, with its array of smart features, can coach patients through training to administration at home.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: noble

IN CASE YOU MISSED IT

  • MedAlliance wins second FDA IDE nod for drug-coated balloon
  • Wells Fargo downgrades Tandem amid rise of automated insulin delivery competition
  • FDA approves first targeted infusion therapy for HER2-low breast cancer
  • Abbott, WeightWatchers partner on diabetes care
  • Insulet up on Q2 sales beat, raised full-year guidance

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS